About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | London Underground Study - Health Effects of Particulate Matter

London Underground Study - Health Effects of Particulate Matter

NCT04614064·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Imperial College London

With

Medical Research Council

Age

40–90

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Give informed consent
London resident
For participants with COPD:
GOLD stage 2 COPD (FEV1/FVC\<70%; 50%\>FEV1\<80% predicted), GOLD stage 3 COPD (FEV1/FVC\<70%; 30%\>FEV1\<50%) and GOLD stage 4 (FEV1/FVC\<70%;FEV1\<30%)
No history of ischaemic heart disease
For healthy volunteers:
No history of ischaemic heart disease.
Normal lung function with no evidence of airflow obstruction.

You may not be if

Those with unstable ischaemic heart disease or COPD.
Current smokers and those who are ex-smokers of \<12 months duration.
Those who work in the London Underground or are occupationally exposed to - - high levels of vehicle traffic exposure on a frequent basis.
Those who cannot walk for 30 mins.
Involvement in another research study
Those unable to give consent.

The record

StatusCompleted

PhaseNo phase

Taking part83

StartedAug 2021

UpdatedJul 24, 2023

Conditions

Chronic Obstructive Pulmonary Disease

Where1

Imperial Clinical Research Facility
London, United Kingdom